Abstract
The understanding of schizophrenia has remarkably expanded over the past few decades, moving beyond the dopamine hypothesis to encompass neurotransmitter interplays, structural brain changes and genetic and environmental determinants. This has led to innovations in therapeutic interventions that offer improved outcomes. This paper explores past and current treatments available for schizophrenia, the latest pharmacological advances and the significance of psychotherapeutic approaches.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
